Beat-to-beat blood pressure variability and Alzheimers disease pathophysiology

Introduction: Elevated blood pressure variability (BPV) is predictive of Alzheimers disease neuropathologic change observed with AD biomarkers. However, prior studies have largely focused on visit-to-visit BPV, which may be influenced by antihypertensive medication adherence and other external factors. Few studies have investigated beat-to-beat BPV, a reliable and direct measure of cardiovascular and autonomic function relevant to AD. Methods: Independently living older adults (N=132) were recruited from the community. Participants underwent continuous blood pressure monitoring and venipuncture. Plasma p-Tau217, p-Tau181, GFAP, NfL, and amyloid-β42/40 ratio were assessed. Linear regression examined the relationship between beat-to-beat systolic BPV and plasma AD biomarkers with and without adjustment for age, sex, systolic blood pressure, and apolipoprotein E4 (APOE4) carrier status. Results: Elevated beat-to-beat BPV was associated with elevated plasma p-Tau217 (β=0.32, p=0.008), plasma p-Tau181 (β=0.22, p=0.05), and plasma GFAP (β=0.41, p=0.00001). Elevated BPV was not associated with plasma amyloid-β42/40 ratio or plasma NfL. Discussion: Increased beat-to-beat BPV is associated with increased Core 1 T1 biomarkers of phosphorylated and secreted AD tau in blood plasma (i.e., pTau217, pTau181), but not with amyloid-β42/40 ratio, a biomarker more exclusively indexing cerebral amyloid retention alone. Elevated BPV was also associated with higher plasma GFAP, a marker of astrocyte reactivity. These findings are consistent with prior studies relating visit-to-visit BPV to AD biomarkers, suggesting that intrinsic cardiovascular and/or autonomic factors underlie links between BPV and AD.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-12
DOI
https://doi.org/10.64898/2026.11.10.26367476
Primary Topic
Dementia and Cognitive Impairment Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Beat-to-beat blood pressure variability and Alzheimers disease pathophysiology

Niema M. Pahlevan, Rond Malhas, Daniel A. Nation, Allison C Engstrom et al.
medRxiv
Dementia and Cognitive Impairment Research
preprint

Beat-to-beat blood pressure variability and Alzheimers disease pathophysiology

Niema M. Pahlevan, Rond Malhas, Daniel A. Nation, Allison C Engstrom, Basant Ismail Lashin, Jillian L. Joyce, Trevor Lohman, Kathleen E. Rodgers, Elizabeth Head, Arunima Kapoor, Aimée Gaubert, Farrah Ferrer, Lorena Contreras, Melanie L. Quiring, Kevin Law, John Paul Alitin
preprint en

Abstract

Introduction: Elevated blood pressure variability (BPV) is predictive of Alzheimers disease neuropathologic change observed with AD biomarkers. However, prior studies have largely focused on visit-to-visit BPV, which may be influenced by antihypertensive medication adherence and other external factors. Few studies have investigated beat-to-beat BPV, a reliable and direct measure of cardiovascular and autonomic function relevant to AD. Methods: Independently living older adults (N=132) were recruited from the community. Participants underwent continuous blood pressure monitoring and venipuncture. Plasma p-Tau217, p-Tau181, GFAP, NfL, and amyloid-β42/40 ratio were assessed. Linear regression examined the relationship between beat-to-beat systolic BPV and plasma AD biomarkers with and without adjustment for age, sex, systolic blood pressure, and apolipoprotein E4 (APOE4) carrier status. Results: Elevated beat-to-beat BPV was associated with elevated plasma p-Tau217 (β=0.32, p=0.008), plasma p-Tau181 (β=0.22, p=0.05), and plasma GFAP (β=0.41, p=0.00001). Elevated BPV was not associated with plasma amyloid-β42/40 ratio or plasma NfL. Discussion: Increased beat-to-beat BPV is associated with increased Core 1 T1 biomarkers of phosphorylated and secreted AD tau in blood plasma (i.e., pTau217, pTau181), but not with amyloid-β42/40 ratio, a biomarker more exclusively indexing cerebral amyloid retention alone. Elevated BPV was also associated with higher plasma GFAP, a marker of astrocyte reactivity. These findings are consistent with prior studies relating visit-to-visit BPV to AD biomarkers, suggesting that intrinsic cardiovascular and/or autonomic factors underlie links between BPV and AD.

medRxiv
University of Southern California (US), University of Arizona (US), University of California, Irvine (US)
Southern California Clinical and Translational Science Institute
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon